Annika Berg

>Education/Background: Ph.Lic. in Analytical Chemistry from Uppsala University. Annika brings 38 years of experience in the pharmaceutical, biotech, life sciences and diagnostics industries, of which 19 years in executive positions.  Annika has held positions as Global Vice President of Quality Assurance & Regulatory Affairs at the Division of Immunodiagnostics at Thermo Fisher Scientific, Global Vice President of Quality Assurance, Regulatory Affairs, and Medical Affairs at Agilent Technologies, Global Vice President of QA/RA at GE Healthcare and Section Manager at Pfizer.
Current Assignments:  Chief Quality Officer at Vectura Fertin Pharma

Holdings: 36 050 Class B shares.
Stock Options: 25 000 TO10, 16 800 SSP 24/27:2 RSU and 50 400 SSP 24/27:2 PRSU.